Here is What Hedge Funds Think About Freeline Therapeutics Holdings plc (FRLN)
In this article we will take a look at whether hedge funds think Freeline Therapeutics Holdings plc (NASDAQ:FRLN) is a good investment right now.
Freeline Therapeutics Holdings Plc (FRLN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Odey Asset Management Group Crispin Odey | 30,131 | $14,463 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 23,764 | $11,832 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 196,390 | $93 | -9% | 0% |
| 4. | Millennium Management Israel Englander | 26,540 | $13 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 21,997,620 | $10,451,069 | 16.58% | |
| 2. | 5,920,765 | $2,917,370 | 0.05% | |
| 3. | 4,814,419 | $2,287,331 | 0.6% | |
| 4. | 4,000,000 | $1,900,400 | 0.27% | |
| 5. | 1,200 | $570,120 | 0% |
News See All
Is FRLN A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether Freeline Therapeutics Holdings plc (NASDAQ:FRLN) is a good investment right now.
Billionaire Hedge Funds
